Regulation of human transmembrane serine protease
AssigneeBayer Schering Pharma Aktiengesellschaft
InventorsXiao Yonghong, Richard W. Gedrich
Life of this patent
Estimating the term…
Abstract
Reagents that regulate human transmembrane serine protease activity and reagents that bind to human transmembrane serine protease gene products can be used to regulate extracellular matrix degradation. Such regulation is particularly useful for treating COPD, metastasis of malignant cells, tumor angiogenesis, inflammation, atherosclerosis, neurodegenerative diseases, and pathogenic infections.
Claims10
A purified polypeptide comprising an amino acid sequence selected from the group consisting of (a) the amino acid sequence shown in SEQ ID NO:
- 12, and (b) the amino acid sequence of the human transmembrane serine protease encoded by a cDNA insert contained within plasmid pCRII-TMSP3 (ATCC Accession No. PTA-3433).
A fusion protein comprising a polypeptide consisting of an amino acid sequence selected from the group consisting of (a) the amino acid sequence shown in SEQ ID NO:
- 12, and (b) the amino acid sequence of the human transmembrane seine protease encoded by a cDNA insert contained within plasmid pCRII-TMSP3 (ATCC Accession No. PTA-3433).
Dependencies are inferred from the claim text.